erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
"we are calling for the immediate implementation of a statutory duty of candour for the health trusts."
.
.
.
one thought on “chess grandmasters show the same longevity advantage as elite athletes”
.
gov. andrew cuomo announced a new lyme and other tick-borne disease control plan tuesday to keep the public informed and free of tick-borne diseases.
.
.
while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain.
.
researchers examined 1,714 samples over six months and found that just 39 per cent contained what they buyer thought they had been sold